NNN-member Pre Diagnostics was established in 2013 by Erik Christensen and Håkon Sæterøy. The company seeks to develop and commercialize an innovative and very effective diagnostic test for Alzheimer’s disease.

NNN will host an exciting neuroscience session at the Nordic Life Science Days in Stockholm 7.-9. September. 

On August 18th, NNN published a newspaper supplement in Dagens Næringsliv. This is the first time NNN makes use of this channel to reach a broader audience. 

Sarsia Seed partner Sveinung Hole joins the NNN board. Erik Christensen reelected as chairman.The annual NNN General Assembly was held in Oslo Science Park on June 10th, in connection with the NNN member meeting and summer party. 

​The HelseOmsorg21 strategy was presented to Prime Minister Erna Solberg and Health Minister Bent Høie Wednesday this week. Read the main priorities here. 

In August this year, NNN will publish a newspaper supplement, which will be distributed with Dagens Næringsliv across Norway. Through this channel, we want to reach out to a wider audience with information about our members and partners, and to share our insights on the strong research and development work among our members.  

The EFNS/ENS Joint Congress of European Neurology took place in Istanbul between May 31st and June 3rd. The congress gathered more than 5000 neurologists from around the world and featured the latest research and development on diseases such as Alzheimer’s, Parkinson’s, epilepsy and multiple sclerosis. 

The journal Nature has announced the current decade as the decade of psychiatry, and the Norwegian government has chosen psychiatry as a prioritized field of research. To continue on this trend, NNN organized a meeting about the future treatment of schizophrenia on the 5th of June.